Bracco steps into virtual reality

Article

Milan-based Bracco, widely known for its contrast agents, has acquired an 80% stake in a company that develops software-based systems that support diagnosis and surgical planning. Volume Interactions was

Milan-based Bracco, widely known for its contrast agents, has acquired an 80% stake in a company that develops software-based systems that support diagnosis and surgical planning. Volume Interactions was founded in 2000 as a spin-off of Kent Ridge Digital Labs, a Singapore research institute focused on information technology. The investment by Bracco reflects the Italian company's evolving strategy of promoting integrated solutions for healthcare, according to Maurizio Denaro, vice president of the Bracco Group's R&D. The acquisition complements the company's line of contrast agents, which constitutes the Bracco Group's core business.

Bracco's involvement with Volume Interactions, publicized Feb. 20, marks the firm's entry into "utilization of the diagnostic image through its manipulation," Denaro said. Products created by Volume Interactions are designed to allow the surgeon to visualize images in 3D and to manipulate the area to be operated on using virtual reality, practicing the various phases of an operation prior to actual surgery. Denaro noted that the technology has already been used successfully in operations to separate conjoined twins. About 10 Volume Interactions' Dextroscopea systems are in use at research centers and international hospitals including the Max Planck Institute in Germany, the radiology department of Johns Hopkins University in Baltimore, and the Mayo Clinic in Rochester, MN.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.